Previous symbols: TAN1.
NOTCH1 is a type I transmembrane receptor that functions as a master regulator of cell-fate determination through juxtacrine signaling. Upon binding membrane-bound ligands (JAG1/2, DLL1/4) on neighboring cells, NOTCH1 undergoes sequential proteolytic cleavages by furin (S1 in Golgi), ADAM10/17 (S2 at plasma membrane), and gamma-secretase (S3/S4), releasing the Notch Intracellular Domain (NICD). NICD translocates to the nucleus where it forms a transcriptional activation complex with RBPJ and MAML coactivators to drive expression of target genes including HES and HEY family members. NOTCH1 plays essential roles in T-cell development, angiogenesis, neurogenesis, heart development, and somitogenesis. Mutations cause T-cell acute lymphoblastic leukemia (activating) and aortic valve disease/Adams-Oliver syndrome (loss-of-function).
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Acute Lymphoblastic Leukemia | somatic driver somatic |
mechanism: T-ALL NOTCH1 and T-Cell Transcriptional Activation
scoped to subtype: T-ALL
|
| Adams-Oliver Syndrome | causative germline |
mechanism: NOTCH1 Haploinsufficiency; Reduced Canonical Notch Signaling
subtype: AOS5
animal model: Mouse (Mus musculus)
scoped to subtype: AOS5
|
| Adenoid Cystic Carcinoma | somatic driver somatic |
mechanism: NOTCH1 Pathway Hyperactivation
|
| Aortic Valve Stenosis | causative |
mechanism: NOTCH1 Loss of Function
|
| Coarctation of the Aorta | susceptibility |
mechanism: Left Ventricular Outflow Tract Developmental Program Disruption
|
| Congenital Heart Disease | causative |
mechanism: Endocardial Cushion Formation and Endothelial-to-Mesenchymal Transition Failure
scoped to subtype: LVOTO
|
| Hypoplastic Left Heart Syndrome | susceptibility germline |
mechanism: Genetic lesion affecting cardiac growth or valvulogenesis
|
| Mixed Phenotype Acute Leukemia | somatic driver somatic |
mechanism: Failure of Lineage Commitment
scoped to subtype: MPAL T/myeloid NOS
|
| Persistent Truncus Arteriosus | unknown de novo | |
| Tetralogy of Fallot | causative germline | |
| Vein of Galen malformation | unknown |
mechanism: Dysregulated Endothelial Developmental Signaling
|
| Esophageal Carcinoma |
untyped
Recurrent Somatic Mutation (ESCC)
|
|
| Esophageal Squamous Cell Carcinoma |
untyped
Squamous Differentiation Pathway Alteration
|
mechanism: NOTCH Pathway Dysregulation
|
| HPV-Negative Head and Neck Cancer |
untyped
Loss-of-Function Mutations
|
mechanism: NOTCH1 Inactivation
|
| IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma |
untyped
Somatic Mutation
|
|
| Vulvar Carcinoma |
untyped
Somatic Mutation
somatic
|
mechanism: HPV-Independent Somatic Driver Accumulation
|
| Glomus Tumor | no genetic record somatic |
mechanism: MIR143-NOTCH Gene Fusion
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| NOTCH1-related AOS spectrum disorder MONDO:1060150 | AD | Definitive 2025-03-07 |
no dismech entry |
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.